SEB Asset Management AB acquired a new position in shares of Humana Inc. (NYSE:HUM – Free Report) in the first quarter, HoldingsChannel reports. The fund acquired 24,228 shares of the insurance provider’s stock, valued at approximately $4,201,000.
Other large investors have also made changes to their positions in the company. Montag A & Associates Inc. grew its position in Humana by 1,880.0% during the fourth quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock valued at $25,000 after acquiring an additional 94 shares during the period. CoreCap Advisors LLC raised its holdings in shares of Humana by 54.4% in the 4th quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock worth $27,000 after purchasing an additional 37 shares during the period. Fideuram Asset Management Ireland dac purchased a new position in shares of Humana in the 4th quarter worth about $27,000. Reflection Asset Management acquired a new position in shares of Humana in the 4th quarter valued at about $29,000. Finally, Larson Financial Group LLC lifted its stake in shares of Humana by 114.1% in the 3rd quarter. Larson Financial Group LLC now owns 152 shares of the insurance provider’s stock valued at $40,000 after purchasing an additional 81 shares in the last quarter. 92.38% of the stock is owned by hedge funds and other institutional investors.
Humana Price Performance
Shares of NYSE HUM opened at $397.93 on Thursday. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.77 and a quick ratio of 1.77. Humana Inc. has a 1-year low of $163.11 and a 1-year high of $428.88. The company has a market capitalization of $47.78 billion, a price-to-earnings ratio of 42.56, a PEG ratio of 2.20 and a beta of 0.71. The business has a 50-day moving average of $360.55 and a 200-day moving average of $263.22.
Wall Street Analyst Weigh In
A number of brokerages have recently issued reports on HUM. Truist Financial boosted their target price on Humana from $320.00 to $415.00 and gave the stock a “hold” rating in a report on Tuesday, July 14th. Robert W. Baird reduced their price target on shares of Humana from $264.00 to $205.00 and set a “neutral” rating on the stock in a research report on Wednesday, April 15th. Royal Bank Of Canada boosted their price objective on shares of Humana from $246.00 to $415.00 and gave the stock a “sector perform” rating in a research note on Thursday, July 9th. Bank of America reissued a “neutral” rating and issued a $410.00 price objective on shares of Humana in a research report on Monday. Finally, Zacks Research raised shares of Humana from a “hold” rating to a “strong-buy” rating in a research note on Monday, July 13th. Two research analysts have rated the stock with a Strong Buy rating, nine have given a Buy rating, fifteen have issued a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $327.17.
Humana Profile
Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.
In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.
Read More
- Five stocks we like better than Humana
- Could Truth API Become Trump Media’s First Meaningful Revenue Driver?
- Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying
- Moog Is More Than a Missile Maker, and Wall Street Is Noticing
- A Boring Dividend Growth Strategy Becomes a Solid Defensive Play
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
